Latest news with #BajajHealthcare
Business Standard
19 hours ago
- Business
- Business Standard
Bajaj Healthcare standalone net profit rises 65.92% in the June 2025 quarter
Sales rise 12.54% to Rs 148.84 crore Net profit of Bajaj Healthcare rose 65.92% to Rs 11.83 crore in the quarter ended June 2025 as against Rs 7.13 crore during the previous quarter ended June 2024. Sales rose 12.54% to Rs 148.84 crore in the quarter ended June 2025 as against Rs 132.25 crore during the previous quarter ended June 2024. Particulars Quarter Ended Jun. 2025 Jun. 2024 % Var. Sales 148.84132.25 13 OPM % 16.4718.53 - PBDT 20.1616.91 19 PBT 14.5210.18 43 NP 11.837.13 66
Business Standard
20 hours ago
- Business
- Business Standard
Market trades sideways in early trade; Nifty trades above 24,700
The key equity indices traded sideways in early trade as investors closely tracking corporate earnings and the delay in trade talks between India and the U.S. The Nifty traded above the 24,700 level. Realty, metal and auto shares advanced while IT, financial services & consumer durables stocks corrected. At 09:30 IST, the barometer index, the S&P BSE Sensex declined 22.37 points or 0.03% to 80,913.39. The Nifty 50 index added 21.25 points or 0.04% to 24,702.25. In the broader market, the S&P BSE Mid-Cap index rallied 0.27% and the S&P BSE Small-Cap index added 0.12%. The market breadth was negative. On the BSE 1,337 shares rose and 1,402 shares fell. A total of 166 shares were unchanged. Foreign portfolio investors (FPIs) sold shares worth Rs 6,082.47 crore, while domestic institutional investors (DIIs) were net buyers to the tune of Rs 6,764.55 crore in the Indian equity market on 28 July 2025, provisional data showed. Stocks in Spotlight: Bajaj Healthcare dropped 5.69%. The companys standalone jumped 51.7% to Rs 12.17 crore on 12.5% increase in net sales to Rs 148.84 crore in Q1 FY26 over Q1 FY25. Quess Corp reported rallied 3.04% after the company reported a 3.75% jump in consolidated net profit to Rs 50.90 crore on 1.8% increase in revenue from operations to Rs 3651.41 crore in Q1 FY26 over Q1 FY25. Waaree Energies jumped 5.02% after the companys consolidated net profit jumped 89.1% to Rs 745.20 crore in Q1 FY26, compared with Rs 394.14 crore in Q1 FY25. Net sales increased 29.8% YoY to Rs 4425.83 crore in Q1 June 2025. Numbers to Track: The yield on India's 10-year benchmark federal paper shed 0.02% to 6.372 from the previous close of 6.374. In the foreign exchange market, the rupee edged lower against the dollar. The partially convertible rupee was hovering at 86.8125 compared with its close of 86.7025 during the previous trading session. MCX Gold futures for 5 August 2025 settlement rose 0.10% to Rs 97,643. The US Dollar Index (DXY), which tracks the greenback's value against a basket of currencies, was up 0.05% to 98.44. The United States 10-year bond yield fell 0.86% to 4.404. In the commodities market, Brent crude for August 2025 settlement gained 03 cents or 0.04% to $70.07 a barrel. Global Markets: Markets in Asia traded in the red as investors awaited the outcome of the ongoing U.S.-China trade talks. Investors also await the result of the U.S. Federal Reserve meeting due Wednesday stateside, where it will make a decision on whether to cut interest rates. On Monday, President Donald Trump announced that a global blanket tariff would likely fall between 15% to 20%. This would affect imports from countries that have not yet negotiated separate trade agreements with the United Statements. Trump had previously announced that baseline tariffs would be just 10%. The presidents tariffs are expected to go into place on August 1. On Wall Street, the S&P 500 closed near the flatline on Monday, with the latest trade deal between the U.S. and EU failing to spark a fresh rally. The broad market index inched up 0.02% to close at 6,389.77, while the Nasdaq Composite gained 0.33% to 21,178.58. The Dow Jones Industrial Average slipped 64.36 points, or 0.14%, to finish the session at 44,837.56.
Business Standard
06-06-2025
- Business
- Business Standard
Bajaj Healthcare slides after WTD Dhananjay Sabaji Hatle resigns
Bajaj Healthcare fell 1.94% to Rs 527.50 after the company informed that Dhananjay Sabaji Hatle, whole-time director (WTD) of the company, has tendered his resignation with immediate effect. Bajaj Healthcare manufactures APIs and branded and generic formulations. It has five API manufacturing plants, located in Tarapur, Maharashtra, and Vadodara, Gujarat; one manufacturing plant of finished formulations in Vadodara, Gujarat; and one manufacturing plant of intermediates in Tarapur, Maharashtra. Bajaj Healthcare reported standalone net profit of Rs 11.18 crore in Q4 FY25 as compared with net loss of Rs 29.92 crore posted in Q4 FY24. However, revenue from operations jumped 15.36% year-on-year (YoY) to Rs 154.47 crore in the quarter ended 31 March 2025.
&w=3840&q=100)
Business Standard
27-05-2025
- Business
- Business Standard
Bajaj Healthcare slips 9% on weak Q4 operational performance; details here
Bajaj Healthcare share price: Pharmaceutical company Bajaj Healthcare share price was under pressure on Tuesday, May 27, 2025, with the scrip dropping up to 8.67 per cent to hit an intraday low of ₹550. At 10:40 AM, Bajaj Healthcare shares continued to trade near day's low level, down 7.51 per cent lower at ₹557 per share. In comparison, BSE Sensex was trading 0.99 per cent lower at 81,360.50 level. Why did Bajaj Healthcare share price fall? Bajaj Healthcare share price dropped today on the back of weak operational performance in the March quarter of FY25 (Q4FY25). The company's earnings before interest, tax, depreciation and amortisation (Ebitda) fell 26.7 per cent year-on-year (Y-o-Y) to ₹11.75 crore in the March quarter of FY25, from ₹16.02 crore in the March quarter of FY24. Ebitda margin contracted to 7.61 per cent in Q4FY25, from 11.97 per cent a year ago (Q4FY24). On the brighter side, the company's profit, or bottom line, came in at ₹11.17 crore, as against a loss of ₹29.92 crore a year ago. Bajaj Healthcare dividend Bajaj Healthcare Board of Directors has recommended a final dividend of 20 per cent i.e. ₹1 per equity share on face value of ₹5 each for FY25, subject to the approval of Shareholders of the Company at the ensuing Annual General Meeting of the Company. About Bajaj Healthcare Bajaj Healthcare, established in 1993, is a among the leading Indian manufacturers specialising in bulk drugs and active pharmaceutical ingredients (APIs). The company develops and supplies a broad portfolio of APIs such as ascorbic acid, citicoline sodium, and carbamazepine, catering to the pharmaceutical, nutraceutical, and food industries. Their commitment to quality and innovation extends to the nutraceutical space as well, with products like Inositol Nicotinate and Magnesium L-Threonate forming part of their specialised offerings. With a strong focus on cost-effectiveness, consistent quality, and timely delivery, Bajaj Healthcare has built a solid global presence. Its customer base spans across international markets, reflecting the company's ability to meet global regulatory standards and diverse client needs.
Business Standard
27-05-2025
- Business
- Business Standard
Bajaj Healthcare reports standalone net profit of Rs 11.18 crore in the March 2025 quarter
Sales rise 15.36% to Rs 154.47 crore Net profit of Bajaj Healthcare reported to Rs 11.18 crore in the quarter ended March 2025 as against net loss of Rs 29.92 crore during the previous quarter ended March 2024. Sales rose 15.36% to Rs 154.47 crore in the quarter ended March 2025 as against Rs 133.90 crore during the previous quarter ended March 2024. For the full year,net profit reported to Rs 39.50 crore in the year ended March 2025 as against net loss of Rs 83.79 crore during the previous year ended March 2024. Sales rose 14.61% to Rs 542.60 crore in the year ended March 2025 as against Rs 473.42 crore during the previous year ended March 2024. Particulars Quarter Ended Year Ended Mar. 2025 Mar. 2024 % Var. Mar. 2025 Mar. 2024 % Var. Sales 154.47133.90 15 542.60473.42 15 OPM % 7.6211.98 - 15.1916.11 - PBDT 19.2616.48 17 73.9355.27 34 PBT 11.739.18 28 46.0127.65 66 NP 11.18-29.92 LP 39.50-83.79 LP
